Dai Ichi Life Insurance Company, LTD Regeneron Pharmaceuticals, Inc. Transaction History

Dai Ichi Life Insurance Company, LTD

  • $3.87 Billion
  • Q3 2025

A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 4,779 shares of REGN stock, worth $3.31 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,779
Previous 3,479 37.37%
Holding current value
$3.31 Million
Previous $1.83 Million 47.15%
% of portfolio
0.07%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$534.91 - $598.71 $695,383 - $778,323
1,300 Added 37.37%
4,779 $2.69 Million
Q2 2025

Aug 13, 2025
SELL
$483.07 - $625.6 $2.87 Million - $3.72 Million
-5,949 Reduced 63.1%
3,479 $1.83 Million
Q1 2025

May 14, 2025
SELL
$634.14 - $744.83 $313,265 - $367,946
-494 Reduced 4.98%
9,428 $5.98 Million
Q4 2024

Feb 13, 2025
SELL
$701.85 - $1046.91 $1.73 Million - $2.59 Million
-2,470 Reduced 19.93%
9,922 $7.07 Million
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $2.44 Million - $2.86 Million
-2,383 Reduced 16.13%
12,392 $13 Million
Q2 2024

Aug 08, 2024
BUY
$883.2 - $1071.19 $98,035 - $118,902
111 Added 0.76%
14,775 $15.5 Million
Q1 2024

May 09, 2024
SELL
$902.69 - $993.35 $3.1 Million - $3.41 Million
-3,433 Reduced 18.97%
14,664 $14.1 Million
Q4 2023

Feb 09, 2024
BUY
$775.18 - $881.7 $581,385 - $661,275
750 Added 4.32%
18,097 $15.9 Million
Q3 2023

Nov 02, 2023
BUY
$692.45 - $844.37 $54,703 - $66,705
79 Added 0.46%
17,347 $14.3 Million
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $10.4 Million - $12.3 Million
-14,794 Reduced 46.14%
17,268 $12.4 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $685,933 - $833,585
1,008 Added 3.25%
32,062 $26.3 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $474,358 - $515,014
672 Added 2.21%
31,054 $22.4 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $573,970 - $724,320
1,000 Added 3.4%
30,382 $20.9 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $7.14 Million - $9.62 Million
-13,018 Reduced 30.7%
29,382 $17.4 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $1.18 Million - $1.38 Million
-1,978 Reduced 4.46%
42,400 $29.6 Million
Q3 2021

Nov 04, 2021
BUY
$574.03 - $680.96 $737,054 - $874,352
1,284 Added 2.98%
44,378 $26.9 Million
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $6.06 Million - $7.16 Million
12,817 Added 42.33%
43,094 $24.1 Million
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $769,715 - $944,548
-1,723 Reduced 5.38%
30,277 $14.3 Million
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $3.99 Million - $5.07 Million
8,340 Added 35.25%
32,000 $15.5 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $2.48 Million - $2.99 Million
4,544 Added 23.77%
23,660 $13.2 Million
Q2 2020

Aug 12, 2020
BUY
$493.32 - $643.92 $4.84 Million - $6.31 Million
9,803 Added 105.26%
19,116 $11.9 Million
Q1 2020

May 08, 2020
BUY
$336.18 - $494.43 $1.51 Million - $2.22 Million
4,500 Added 93.5%
9,313 $4.55 Million
Q4 2019

Feb 13, 2020
SELL
$274.13 - $376.51 $1.37 Million - $1.88 Million
-5,000 Reduced 50.95%
4,813 $1.81 Million
Q1 2019

May 14, 2019
BUY
$372.08 - $439.57 $42,045 - $49,671
113 Added 1.16%
9,813 $4.03 Million
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $10,183 - $11,846
-29 Reduced 0.3%
9,700 $3.92 Million
Q2 2018

Aug 10, 2018
SELL
$284.6 - $344.99 $402,993 - $488,505
-1,416 Reduced 12.71%
9,729 $3.36 Million
Q3 2017

Nov 09, 2017
BUY
$431.38 - $504.0 $4.81 Million - $5.62 Million
11,145
11,145 $4.98 Million

Others Institutions Holding REGN

# of Institutions
1,468
Shares Held
86.5M
Call Options Held
2.38M
Put Options Held
1.61M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email